female scientist performing test with pipette in laboratory setting
Scientist in laboratory setting (symbolic photo)

Image source: Unsplash/Julia Koblitz

News • Early detection of coronavirus presence

Covid-19 wastewater testing: new quantification kit launched

Life science research and clinical diagnostics company Bio-Rad Laboratories announced the launch of its PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit, a tool to detect the virus that causes Covid-19 in a community’s wastewater.

"With wastewater testing becoming more widely adopted, this assay provides the ability for a community to determine if the virus is present days to weeks before the virus may be detected in individuals," said Simon May, Bio-Rad Senior Vice President, Digital Biology Group. "As we continue to manage the spread of Covid-19, it is especially important to have a highly sensitive early warning system that can be implemented on a community-wide basis," he said. ddPCR technology is recommended in the Centers for Disease Control and Prevention guidelines (CDC) for wastewater testing, and use of the technology has been published by the Environmental Protection Agency (EPA) as a dependable method to quantify viruses in wastewater.

The PREvalence ddPCR SARS-CoV-2 Wastewater Quantification Kit includes all reagents needed to detect the virus in wastewater along with software for automated analysis. The test runs on Bio-Rad's QX200 Droplet Digital PCR System, QX200 AutoDG Droplet Digital PCR System, and the QX ONE Droplet Digital PCR System. It joins Bio-Rad's menu of Covid-19 products that are being used in the global fight against Covid-19. Other products include molecular qPCR and ddPCR instruments and assays, antibody tests, quality controls, and ddPCR assays to detect SARS-CoV-2 variants of concern.

Source: Bio-Rad Laboratories 


Related articles


News • HPV oncoprotein quantification

Urine test improves cervical cancer early detection

A new test shows promise in making cervical cancer screening more accessible and less invasive by detecting oncoproteins of the human papillomavirus (HPV) in urine samples.


Article • Cervix, vulva and vagina

More certainty with methylation tests for early detection of cancer

A second-generation lab test for early detection of cervical cancer is the most recent addition to Oncgnostics’ portfolio. In particular, the company’s solution will help women in countries with…


Sponsored • Promising combination: AFP, AFP-L3, DCP and GALAD score

Enhanced early detection of liver cancer

Worldwide, about one million people are suffering from hepatocellular carcinoma (HCC). In Germany alone, there are 9,000 new patients each year, most of them men between 50 and 60 years. When liver…

Related products

Subscribe to Newsletter